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Abstract
α2A adrenergic receptor (α2A-AR) activation has been shown in animal models to play an 
important role in regulating the balance of acute pain inhibition vs. facilitation after both physical 
and psychological stress. To our knowledge the influence of genetic variants in the gene encoding 
α2A-AR, ADRA2A, on acute pain outcomes in humans experiencing traumatic stress has not 
been assessed. In this study, we tested whether a genetic variant in the 3′UTR of ADRA2A, 
rs3750625, is associated with acute musculoskeletal pain (MSP) severity following motor vehicle 
collision (MVC, n = 948) and sexual assault (n = 84), and whether this influence was affected by 
stress severity. We evaluated rs3750625 because it is located in the seed binding region of 
miR-34a, a microRNA (miRNA) known to regulate pain and stress responses. In both cohorts, the 
minor allele at rs3750625 was associated with increased MSP in distressed individuals 
(stress*rs3750625 p = 0.043 for MVC cohort and p = 0.007 for sexual assault cohort). We further 
found that (1) miR-34a binds the 3′UTR of ADRA2A, (2) the amount of repression is greater 
when the minor (risk) allele is present, (3) miR-34a in the IMR-32 adrenergic neuroblastoma cell 
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line affects ADRA2A expression, (4) miR-34a and ADRA2A are expressed in tissues known to 
play a role in pain and stress, (5) following forced swim stress exposure, rat peripheral nerve tissue 
expression changes are consistent with miR-34a regulation of ADRA2A. Together these results 
suggest that ADRA2A rs3750625 contributes to post-stress MSP severity by modulating miR-34a 
regulation.
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Introduction
Exposure to traumatic stress is, unfortunately, common in life.[42] For example, in America 
each year more than eleven million individuals experience a motor vehicle collision (MVC) 
and nearly 700,000 women are sexually assaulted.[1; 49] The precise molecular mechanisms 
influencing acute MSP severity after stressful events such as MVC and sexual assault remain 
poorly understood.
α2A adrenergic receptor (α2A-AR) activation has been shown to influence pain outcomes in 
both pre-clinical and human studies.1-10 These data include animal model data 
demonstrating that α2A-AR activation plays an important role in regulating the balance of 
acute pain inhibition vs. facilitation after both physical and psychological stress.[19] 
However, to our knowledge the influence of α2A-AR activation on acute MSP outcomes in 
humans experiencing traumatic stress has not been assessed. One way to assess the potential 
influence of α2A-AR activation on acute MSP in trauma-exposed individuals is to evaluate 
for associations between genetic variants influencing α2A-AR function and acute MSP 
outcomes. If α2A-AR activation influences acute MSP severity in humans experiencing 
traumatic stress, then inherited differences in the gene for α2A-AR, ADRA2A, should be 
associated with individual differences in acute MSP severity. Few studies have examined 
associations between ADRA2A polymorphisms and responses to stress generally or pain 
outcomes specifically. One 2004 study of healthy volunteers found that a polymorphism in 
the 3′UTR (3′untranslated region) of ADRA2A modulates autonomic responses to 
physiological and environmental stress,[23] and another study of healthy volunteers found 
that ADRA2A polymorphisms predict evoked pain responses.[32] To our knowledge, no 
prospective cohort studies have evaluated associations between ADRA2A genetic variants 
and clinical acute MSP outcomes following trauma/stress exposure.
In this study, we assessed the association between a single nucleotide polymorphism (SNP) 
in the 3′UTR of ADRA2A, rs3750625, and acute MSP outcomes among individuals 
experiencing MVC and sexual assault. We evaluated this SNP because bioinformatics 
analyses indicate that it is in the seed binding region of miR-34a, a miRNA known to affect 
pain and stress responses.[27; 60] Increasing evidence indicates that one common 
mechanism by which genetic polymorphisms influence cellular function is by altering 
miRNA seed binding regions, thus altering the ability of miRNA to bind and regulate mRNA 
and the amount of protein product produced.[2] When assessing the association between 
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rs3750625 and acute MSP outcomes, we included potential gene variant × sex and gene 
variant × stress interactions, because genetic influences on MSP after stress exposure are 
often sex and/or stress severity dependent (e.g.,[8; 39; 58]). We then experimentally tested 
whether the allele present at rs3750625 affects miR-34a binding to the 3′UTR of ADRA2A, 
and whether miR-34a and ADRA2A expression levels change in key tissues involved in 
stress-induced hyperalgesia in an animal model of stress exposure.
Methods
Motor Vehicle Collision Cohort
Study design and population—The methods of the MVC study have been described.
[45] In brief, individuals ≥ 18 and ≤ 65 years of age presenting to one of eight EDs in four 
no-fault insurance states within 24 hours of MVC who did not have fracture or other injury 
requiring hospital admission were enrolled. Patients who were not alert and oriented were 
excluded, as were pregnant patients, prisoners, patients unable to read and understand 
English, patients taking a β-adrenoreceptor antagonist, or patients taking opioids above a 
total daily dose of 30 mg of oral morphine or equivalent. In addition, enrollment was limited 
to non-Hispanic whites (the most common ethnicity at study sites). Informed consent was 
obtained from all participants and Institutional Review Board (IRB) approval was obtained 
at all study sites.
DNA collection and genotyping—Study personnel collected blood samples at the time 
of enrollment using PAXgene DNA tubes. Following DNA purification (PAXgene blood 
DNA kit, QIAGEN), genotyping using the Sequenom platform was performed at rs3750625. 
As described above, this SNP was chosen for analysis based on its location in a regulatory 
region of the pain and stress-associated gene, ADRA2A, and because bioinformatics 
analyses suggest that this allele might affect miR-34a binding.([12; 37; 50; 62]) Two 
Hapmap samples and two repeat samples were included in each genotyping batch of 96 
samples to ensure genotyping accuracy and reliability. rs3750625 was in Hardy-Weinberg 
equilibrium (p > .05), and repeat genotyping demonstrated greater than 98% call agreement.
Assessments—Acute MSP severity was assessed in the ED using a verbal 0-10 numeric 
rating scale (NRS).[9] Distress in the ED was measured using the Peritraumatic distress 
inventory.[11] A validated cut-off of 23 was used to identify those with substantial distress.
[41]
Sexual Assault Cohort
Study design and population—The methods of the sexual assault study have been 
reported.[4; 38] In brief, women 18 years of age or older who presented to one of ten Sexual 
Assault Nurse Examiner (SANE) programs in four states for medical care within 72 hours of 
sexual assault were recruited. Women unable to give informed consent (e.g., due to 
intoxication) were excluded, as were women who were hospitalized after sexual assault, 
lived with their assailant, were prisoners, were pregnant, did not have a telephone, and/or did 
not live within driving distance for follow-up interviews. Institutional Review Board (IRB) 
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approval was obtained at all study sites and all study participants provided written informed 
consent.
DNA collection and genotyping—Saliva specimens were obtained at one week follow-
up evaluations using Oragene DNA Self-Collection Kits. Following DNA purification, 
genotyping was performed within the same batches as MVC cohort samples. Hapmap 
samples and two repeat samples were included in each genotyping batch to ensure genotypic 
accuracy and reliability; repeated genotyping demonstrated greater than 98% call agreement, 
and rs3750625 was in Hardy-Weinberg equilibrium (p > .05).
Assessments—Acute MSP severity was assessed in the ED using a verbal 0-10 NRS. 
One week after the assault, sexual assault survivors completed an in-person computerized 
self-report questionnaire which included an assessment of the individual’s distress levels at 
the time of assault using the Acute Stress Disorder (ASD) questionnaire.[13] The ASD is a 
19-item questionnaire assessing feelings that were experienced during or immediately after 
the assault. Each item on the questionnaire was evaluated via numeric rating scale from 0 
(no distress) to 5 (high distress). A cut-off of 56 for substantial acute stress (ASD scale) has 
been reported previously.[13] However, over 90% of the participants in the sexual assault 
cohort reported distress levels above this threshold, thus we used the median score of 77 to 
distinguish more vs. less distressed sexual assault survivors.
Statistical analyses—Sociodemographic characteristics of the sample were summarized 
using standard descriptive statistics. General linear models were used to evaluate the 
association between rs3750625 with acute MSP outcomes and for potential sex × rs3750625 
and stress × rs3750625 interactions, adjusting for potential confounding by age and study 
site. Sex and stress-dependent effects were evaluated because of increasing evidence that 
such interactions are frequently present (e.g.,[8; 39; 58]) and because such effects have been 
found in ADRA2A previously.[19; 23] A dominant genetic model (homozygous for major 
allele vs. other) was used in all analyses due to the low minor allele frequency (MAF = 0.05) 
for rs3750625 in European Americans. Mean levels of MSP in distressed and non-distressed 
individuals homozygous for the major allele (CC) or individuals heterozygous or 
homozygous for the minor allele (CA/AA) were obtained from general linear models. All 
statistical analyses were completed using SPSS software (v.23; SPSS Inc, Chicago, IL).
Bioinformatics analyses—The miRdSNP online algorithm (http://
mirdsnp.ccr.buffalo.edu/search.php) was used to identify whether rs3750625 was predicted 
to affect microRNA (miRNA) binding.[12] The UCSC genome browser (https://
genome.ucsc.edu/) was used to determine species conservation.[28] RNA hybrid (http://
bibiserv.techfak.uni-bielefeld.de/rnahybrid/) was used to predict the secondary structure of 
the miR-34a-ADRA2A binding event.[33]
Constructs—Lentiviral constructs containing either a firefly luciferase gene (pL-SV40-
GL3) or a renilla luciferase gene (pL-SV40-RLUC) were used for dual luciferase assays.[26] 
The 3′UTR of ADRA2A was amplified from human genomic DNA using primers 1-F and 
1-R (Supplementary Table 1). The resullting 1360bp product was cloned downstream of the 
firefly luciferase gene in pL-SV40-GL3 using XhoI and EcoRI restriction enzyme sites. This 
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newly created construct, pL-GL3-ADRA2A-maj, was sequenced to confirm the major allele, 
C, at position rs3750625 in the ADRA2A 3′UTR, and was then used as template to mutate 
the major allele to the minor allele, A, using the QuickChange II Site-Directed Mutagenesis 
Kit (Promega) and primers 2-F and 2-R (Supplementary Table 1). The construct containing 
the minor allele was named pL-GL3-ADRA2A-min.
Seed region and compensatory region mutations were made in the ADRA2A 3′UTR using 
two-step PCR. pL-GL3-ADRA2A-maj was used as the parent construct, and primers 
containing mutant sequence at either the seed region or compensatory site were used to 
create constructs pL-GL3-ADRA2A-seed (Primers 1-F, 1-R, 7-F, and 7-R, Supplementary 
Table 1) and pL-GL3-ADRA2A-comp (Primers 1-F, 1-R, 6-F, 6-R, Supplementary Table 1), 
respectively. The pcDNA-based miR-34a expression construct (pC-34a) was generously 
donated by Moshe Oren (The Weizmann Institute of Science).
pLCE-s34 and associated controls, pLCE and pLCE sCXCR4 were generously donated from 
the Luftig Lab (Duke University). Generation of these constructs and the efficacy with 
which pLCE-s34 knocks down miR-34a expression has been previously descibed.[24]
Cell culture and generation of neuroblastoma cells stably knocked down for 
miR-34a expression—HEK293T cells were grown in Dulbecco’s Modified Eagle’s 
Medium (DMEM) with 10% fetal bovine serum (FBS) and 1% gentamicin. IMR-32 cells are 
human adrenergic neuroblastoma cells with high levels of the catecholamine precursor, 
tyrosine hydroxylase.[61] They were cultured in Eagle’s Minimum Essential Medium 
(EMEM) with 10% FBS and 1% gentamicin. All cells were incubated at 37°C, 5% CO2.
To address whether miR-34a plays a significant role in regulating endogenous levels of 
ADRA2A, we suppressed miR-34a activity in the IMR-32 neuroblastoma cell line. miR-34a 
activity was inhibited by transduction of these cells with a GFP-based lentiviral miRNA 
sponge specific for miR-34a (s34). miRNA sponges represent a well-established technique 
[21; 36; 59] for specifically and stably blocking the activity of an miRNA through 
overexpression of an mRNA containing the GFP indicator gene linked to multiple (in this 
case, four) copies of an incompletely complementary artifical target site for the miRNA of 
interest. This particular miR-34a sponge has previously been shown to result in robust 
knockdown of miR-34a.[24]
We also separately transduced a previously described [26] control lentiviral miRNA sponge 
vector (sCXCR4) which expresses a sponge specific for a small interfering RNA that 
inhibits CXCR4 mRNA expression. The second control vector represents the parental 
lentiviral vector expressing only GFP (pLCE). Viral transductants for pLCE-s34 were 
produced in HEK293T cells using a third generation lentiviral packaging system [20] 
consisting of pMD2-VSVG, pRSV-REV, pMDLgp, and either pLCE-s34 (‘s34’), pLCE 
(GFP control), or PLCE-sCXCR4 (‘sCXCR4’, a control sponge). HEK293T cells were 
transfected using Fugene 6 Reagent (Promega). 48 hours after transfection, viral media was 
collected, filtered, and concentrated using Amicon Ultra centrifugal columns, then added to 
the culture medium atop IMR-32 cells, and integration of sponge sequence was monitored 
by GFP expression. Cells with the top 30% mean GFP fluorescence were sorted using FACS 
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analysis (ARIA II) and grown in culture until sufficient numbers of cells were available for 
RNA isolation via TRIzol (Life Technologies) or for protein isolation via RIPA buffer 
(Pierce).
Dual luciferase assays—Binding of miR-34a to ADRA2A was assessed using the above 
described FLUC and RLUC-based indicator vectors, pL-SV40-GL3 and pL-SV40-RLUC. 
HEK293T cells were co-transfected with pC-34a, pL-SV40-RLUC, and either pL-GL3-
ADRA2A-maj or pL-GL3-ADRA2A-min using Fugene 6 Transfection Reagent (Promega). 
To asses dose-dependent binding, 20fmol, 60fmol, and 120fmol of pC-34a were used. For 
seed vs compensatory binding experiments, 150fmol of pC-34 was used.
Seventy-two hours after transfection, cells were collected and lysed. RLUC and FLUC levels 
were measured on a SpectraMax microplate reader (Molecular Devices) using substrates 
from a dual luciferase reporter assay kit as described (Promega); FLUC values were 
normalized to RLUC values.
RT-qPCR and Western blotting—miRNA expression was measured by stem-loop 
reverse transcription- quantitative PCR (RT-qPCR). Total RNA was prepared with TRIzol 
reagent according to the manufacturer’s instructions and 10 ng of total RNA per reverse 
transcription reaction was used. Primers for RT and probes for quantitative PCR (TaqMan) 
were ordered from Life Technologies and used as directed. miR-34a expression levels 
(microRNA assay number 000426; Life Technologies) were normalized to RNU48 (human 
samples) or U87 (rat samples) (assay numbers 001006 and 001712, respectively; Life 
Technologies).
For analysis of ADRA2A mRNA expression, RNA was first treated with DNaseI (New 
England Biolabs) to remove genomic DNA. Random primers were used for reverse 
transcription as described (High Capacity Reverse Transcription Kit, Life Technologies) and 
SYBR reagents were used for qPCR with transcript specific primers as instructed (Life 
Technologies). Primer sequences for detecting ADRA2A mRNA in humans and rats are 
shown in Supplementary Table 1. Endogenous control primers were designed against B2M 
(human) and Beta actin (Rat); their sequences are also shown in Supplementary Table 1.
To compare α2A-AR protein levels after miR-34a knock-down, protein was isolated from 
cells using RIPA buffer (ThermoFisher Scientific) and protease inhibitors (ThermoFisher 
Scientific). Total protein concentrations were measured with a BCA Protein Assay (Pierce) 
and equal amounts of protein (26μg per lane) were loaded onto a 4-12% Bis-Tris gel 
(LifeTechnologies) and analyzed by Western blotting. Primary rabbit anti-ADRA2A was 
from Boster Antibody and ELISA Experts (PA2197), and primary rabbit anti-β-actin was 
from Cell Signaling Technology (13E5, #4970). Secondary anti-rabbit IgG HRP was from 
Cell Signaling Technology (#7074). Signals were developed using ECL Western Blotting 
Substrate (Pierce) and in accordance with product literature, bands corresponding to ~50kDa 
were identified as ADRA2A.
Animal studies—The US Army Institute of Surgical Research Institutional Animal Care 
and Use Committee approved the described animal study, which was conducted in 
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compliance with the Animal Welfare Act, Animal Welfare Regulations, and the principles of 
the Guide for the Care and Use of Laboratory Animals and conformed to federal guidelines. 
All efforts were made to minimize the number of animals used in these experiments and to 
minimize potential suffering.
Six adult (200-225g) male Sprague-Dawley rats (Charles River Laboratories, Wilmington, 
MA) were pair housed in a 12:12 hour light: dark cycle with ad libitum access to food and 
water. To induce stress, rats were individually placed in cylindrical polyethylene containers 
measuring 30-cm in diameter and 50-cm in height and containing 20-cm of room 
temperature water for 20 minutes, as previously described.[46] This was sufficient to force 
the rats to swim, as they were unable to reach the bottom of the cylinder. Baseline (no stress) 
subjects were placed in empty cylinders. Swim sessions were performed once daily for three 
consecutive days. All rats were towel dried and returned to clean cages following each 
session, and were observed for behavioral signs of distress.
Twenty-four hours following stress/sham exposure, rats were given an overdose of 
pentobarbital sodium. The following tissues were collected: adrenal glands, peripheral 
nerves, and dorsal root ganglion from L2-L5. Each tissue was isolated and immediately 
stored in RNA later (ThermoFisher) at −80°C. RNA was isolated using Trizol and RNA 
concentration was measured using a NanoDrop 2000 (Thermo Scientific).
Results
Cohort characteristics
Characteristics of study participants in the initial cohort (MVC, n = 948) and replication 
cohort (sexual assault, n = 84) are shown in Table 1. In the MVC cohort all participants were 
European American and the majority of the participants were women. For the sexual assault 
cohort, the majority of the participants were European American and all study participants 
were women. In general, individuals experiencing MVC were older than sexual assault 
participants, reported less overall MSP in the ED, and had less distress at the time of trauma.
ADRA2A rs3750625 is located within the seed region of a predicted binding site for 
miR-34a
Based on computational data from the online algorithm, miRdSNP, ADRA2A rs3750625 is 
located in the seed binding region for miR-34a.[12] The minor allele, A, at ADRA2A 
rs3750625 is predicted to create an A-U base-pair between miR-34a and ADRA2A, 
increasing seed region binding affinity between miR-34a and ADRA2A. This position is 
unpaired if miR-34a binds the ADRA2A major allele (C, Figure 1A). Examination of the 
full miR-34a binding region of ADRA2A revealed that this region in general, and the seed 
region in particular, is highly conserved across mammalian species, suggesting that this is an 
important miRNA binding site (Figure 1B).
Acute MSP following MVC and sexual assault
In initial general linear models, the influence of ADRA2A rs3750625 on acute MSP severity 
after both MVC and sexual assault depended on the level of peritraumatic stress (Table 2). 
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Because of this interaction, the influence of ADRA2A rs3750625 was subsequently 
evaluated among individuals with higher and lower levels of peritraumatic stress separately.
ADRA2A rs3750625 influences acute MSP severity among individuals with higher levels of 
peritraumatic distress
Individuals who reported higher levels of peritraumatic stress during and after sexual assault 
and had one or more copies of the ADRA2A rs3750625 minor allele (CA/AA) experienced 
more severe acute MSP following sexual assault than individuals homozygous for the major 
allele (CC = 9.3 vs CA/AA = 8.4, p = 0.020, Figure 2). The same direction of effect and very 
similar effect size was observed in the MVC cohort among those who reported higher levels 
of peritraumatic stress during and after the MVC, although this difference did not reach 
statistical significance (CC = 7.1 vs CA/AA = 6.3, p = 0.120, Figure 2).
miR-34a binds to the 3′UTR of ADRA2A
To experimentally test whether miR-34a binds to the 3′UTR of ADRA2A, we cloned the 
full ADRA2A 3′UTR downstream of a firefly luciferase reporter gene and performed dual 
luciferase reporter assays.[26] Somewhat surprisingly, given imperfect predicted seed 
binding, miR-34a binding to the 3′UTR of ADRA2A caused a dose-dependent decrease in 
luciferase production with the major allele (Figure 3A).
The ADRA2A rs3750625 allele affects miR-34a binding in vitro
We next compared binding of miR-34a to the 3′UTR of ADRA2A in the presence of the 
minor allele. Consistent with miRdSNP prediction of increased base pairing of miR-34a to 
the ADRA2A 3′UTR seed region in the presence of the minor allele (Figure 1A), decreased 
luciferase production was observed in the presence of the minor allele vs the major allele at 
all concentrations of miR-34a (Figure 3B).
The seed region of the miR-34a binding site in the 3′UTR of ADRA2A confers the majority 
of miR-34a binding specificity in vitro
Because we observed binding of miR-34a to the 3′UTR of ADRA2A with the major allele 
present, which is not predicted to form perfect seed pairing (suggesting a possible 
3′compensatory binding mechanism [5]), we made mutations in both the seed region and the 
compensatory region of the ADRA2A 3′UTR and tested miR-34a binding (Figure 3C). Dual 
luciferase reporter assays demonstrated that the majority of binding between miR-34a and 
the ADRA2A 3′UTR is conferred through the seed sequence (Figure 3D), and that this 
binding site is the only miR-34a site in the ADRA2A 3′UTR. (No binding was observed 
when this seed site was mutated).
miR-34a regulates endogenous expression of ADRA2A in cell culture
ADRA2A mRNA and protein levels were assayed in an IMR-32 neuroblastoma cell line 
stably expressing a miR-34a sponge. (IMR-32 cells exhibit adrenergic neurotransmitter 
properties [47; 61] and express both miR-34a and ADRA2A (Supplementary Figure 1).) 
ADRA2A mRNA levels (measured via RT-qPCR) increased by 2.5 fold in the absence of 
miR-34a (Figure 4A, p <0.05, Mann Whitney U test). Consistent with this result, using 
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Western Blotting, we also detected an increase in the level of ADRA2A protein in the 
presence of the miR-34a sponge, as compared to pLCE and sCXCR4 controls (Figure 4B).
miR-34a and ADRA2A are co-expressed in rat tissues relevant to pain and stress and their 
expression levels change in response to forced swim stress exposure
For regulation to occur in vivo, miR-34a and ADRA2A must both be expressed in stress-
relevant tissues. Previous animal model studies have shown that pain development following 
stress exposure is influenced by the release of catecholamines from the adrenal gland that 
then sensitize peripheral nociceptors.[19; 29] We therefore examined miR-34a and 
ADRA2A mRNA expression in the adrenal gland, peripheral nerve, and dorsal root ganglion 
(DRG), both before and after forced swim stress.
Peripheral nerve and DRG
Consistent with previous reports, ADRA2A mRNA and miR-34a were both expressed in the 
DRG [3; 25; 55; 56] and peripheral nerve tissue, with higher levels of each RNA in the DRG 
(Supplementary Figure 2). Following forced swim stress exposure, ADRA2A mRNA levels 
decreased in the peripheral nerve (Figure 5). In contrast, in peripheral nerve tissues miR-34a 
expression levels increased. No change in ADRA2A mRNA or miR-34a expression was 
detected in the DRG.
Adrenal gland
ADRA2A and miR-34a were also expressed in the adrenal gland, at lower levels than in the 
peripheral nerve and DRG (Supplementary Figure 2). Swim stress exposure had little to no 
effect on adrenal gland ADRA2A or miR-34a expression levels (Figure 5).
Discussion
To our knowledge, the present report is the first to provide evidence that acute MSP severity 
following traumatic stress exposure is influenced by microRNA regulation of the expression 
of an important stress/pain gene (i.e., ADRA2A). In addition, our results indicate that a 
specific SNP in the ADRA2A gene nucleotide sequence, where miR-34a binds, affects acute 
MSP variability. Specifically, our results suggest that distressed individuals with the 
rs3750625 minor allele experience an approximately 1 point increase (on a 0-10 NRS scale) 
in acute MSP after MVC trauma or sexual assault, due to the fact that the 3′UTR of the 
ADRA2A gene is bound more efficiently by miR-34a when the minor allele is present. 
Importantly, the influence of the rs3750625 allele was stress dependent. This finding is 
consistent with the known regulation of miR-34a by stress,[18; 27] and suggests that 
activation of the same physiologic systems which result in subjective symptoms of stress/
distress also increase the expression of miR-34a and enhance the impact of the rs3750625 
allele on the cell physiology of stress-relevant tissues and resulting phenotype. These data 
also provide an example of the important influence of stress-induced hyperalgesia on clinical 
pain outcomes after trauma exposure, and provide data supporting a physiologic mechanism 
by which increased stress causes increased acute MSP, distinct from traditionally 
hypothesized mechanisms such as muscle tension.[43]
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Donello et al previously showed that, in the absence of ADRA2A, animals exhibit acute 
hyperalgesia (vs analgesia) following exposure to sound and footshock stressors.[19] Our 
results showing that trauma-exposed individuals with the minor allele at rs3750625 have 
increased miR-34a binding to ADRA2A, reduced ADRA2A transcript, and increased acute 
MSP are consistent with these pre-clinical data. In addition, data from Donello et al, together 
with data from Levine and collegues, indicate that low levels of peripherally located α2A-
AR receptors lead to reduced feedback inhibition of norepinephrine release in response to 
stress.[19; 30] Norepinephrine can sensitize sensory afferents, thus high levels of this 
neurotransmitter (due to low levels of α2A-AR) result in increased hyperalgesia.[31] Our 
data indicate that expression levels of ADRA2A and miR-34a RNAs change in peripheral 
nerves in response to stress. If miR-34a binds ADRA2A more efficiently in individuals with 
the risk allele, then reduced levels of α2A-AR in such individuals would be anticipated to 
result in higher circulating levels of norepinephrine and greater afferent sensitization. Future 
studies measuring α2A-AR gene expression and circulating levels of catecholamines in 
trauma-exposed individuals with the major vs. minor allele could test this hypothesis.
Our results and those from other groups suggest that miR-34a regulation of ADRA2A is 
likely to be tissue-specific. In our study, we assayed three stress-sensitive rat tissues (the 
adrenal gland, DRG, and peripheral nerves) for biologically relevant overlapping expression 
of miR-34a and ADRA2A mRNA and for expression level changes following stress 
exposure. Though the two RNAs were co-located in all three tissues, change in expression 
following stress exposure was only consistent with direct miR-34a regulation of ADRA2A 
in the peripheral nerves. These data are consistent with previous reports, which have also 
suggested that miR-34a and ADRA2A expression changes following stress exposure are 
tissue (and perhaps stress) specific. For example, ADRA2A expression in the locus corelus 
of Wistar and Wistar-Kyoto rats exhibited no change following acute restraint stress,[51] 
whereas ADRA2A was significantly downregulated in the bed nucleus of the stria terminalis 
in response to repeated footshock stressors.[34] The fact that miR-34a and ADRA2A 
interaction is likely tissue-specific suggests important implications regarding potential 
therapeutic targeting of miRNA, since miR-34a has also been shown to play roles in 
tumorigenesis and cardiac function.[6; 7; 17; 24; 48; 53; 57] In other words, to avoid off-
target effects, such treatment would likely need to be specifically targeted to pain-relevant 
tissues. Of note, in addition to ADRA2A, predicted or experimentally validated targets of 
miR-34a and/or miR-449 (a member of the same miRNA family) include gene transcripts 
such as COMT, CRHR1, SLC6A1, NOTCH1, and ADCY5.[14; 18; 40; 52] The effect of 
miR-34a/miR-449 on these transcripts, and/or polymorphisms in these genes affecting 
miRNA binding, may also influence acute or persistent MSP outcomes after trauma 
exposure. Therefore, future studies examining more general transcriptional changes in 
miR-34a-influenced genes following different types of stress and/or pain exposures are 
warranted.
We focused on rs3750625 in ADRA2A because it was predicted to affect a miR-34a binding 
site by the miRdSNP online database. Interestingly, however, because there is not perfect 
complimentarity between the seed region of ADRA2A with the major allele and miR-34a, 
other miRNA target prediction algorithms such as TargetScan and DIANA MicroT-CDS 
were not able to predict a binding event at this location. Therefore, our approach enabled us 
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to uncover a miRNA binding event that would not have been discovered using traditional 
algorithm-based miRNA target identification techiques. Additionally, because of the general 
importance of seed binding for miRNA-mRNA interactions,[35] we hypothesized that we 
would detect less binding with the major allele than we observed. This observed binding led 
us to test whether miR-34a bound non-canonically, ie via the compensatory region.[5] 
Surprisingly, we found that the binding activity was in fact conferred through the seed 
region, providing evidence that a seed region with a single mismatch can still confer 
binding. Despite the evident importance of seed region binding in the present study, many 
non-seed region target sites (with a wobble base pair or bulge in the seed) have been 
identified and are of high biologic relevance.[10; 16; 22]
Our data is interesting in that it might shed light on a finding from a paper published in 2004 
showing that a genetic association in the 3′UTR of ADRA2A is associated with 
physiological reponses to stress.[23] In this manuscript, the authors showed that the minor 
allele of a polymorphism in a DraI site caused rapid degradation of the mRNA. Upon 
examination of the ADRA2A 3′UTR, there are four DraI sites; the functional polymorphism 
examined in the 2004 manuscript encompasses rs553668 and is located 22nt upstream of 
rs3750625. Although this site is immediately outside of the miR-34a binding region, it is 
still possible that the allele affects miR-34a binding through indirect mechanisms such as 
RNA folding or protein binding.[2] Because miRNA were not widely studied until the early 
part of the millenium, it is likely that the authors of this paper did not consider potential 
effects of miRNA.
Some limitations should be considered when interpreting the results of this study. First, we 
focused on a single polymorphism instead of analyzing SNP association with acute pain 
outcomes using previously established haplotypes.[54] It is therefore possible that other 
polymorphisms in LD with rs3750625 such as rs1800763 also serve as functional 
polymorphisms that work cooperatively with rs3750625-mediating miRNA binding changes 
to affect ADRA2A mRNA levels. Second, our genetic association results were not as 
significant in our large MVC cohort as they were in the smaller sexual assault cohort. This 
could be due to the relative frequency of the minor allele in European Americans (5% in the 
MVC cohort) vs in African Americans (~15%). Thus in the sexual assault cohort, which is 
over one-third African American (n = 30, 36%), we might have had more statistical power to 
detect differences. Third, because miR-34a and ADRA2A are predominately expressed in 
tissues that are not feasible to collect in a live human cohort, we were not able to examine 
whether levels of these RNA differ in individuals with the major vs minor allele. However, 
in future studies, it would be interesting to measure plasma catecholamine levels (with the 
caveat that quantification is difficult and not always reliable[15; 44]) in these individuals. 
Fourth, animal and cell culture experiments included in this study used a single animal line, 
Sprague Dawley rats, and a single cell culture line, IMR-32 neuroblastoma cells. Future 
studies should evaluate experimental results in additional animal and cell lines. Finally, we 
did not directly measure the effects of miR-34a on MSP severity following stress exposure 
in animals. It would be interesting to examine acute hyperalgesia following stress exposure 
in animals that do not express miR-34a.
Linnstaedt et al. Page 11
Pain. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgements
We would like to thank the participants for taking part in this study.
Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and 
Skin Diseases of the National Institutes of Health under Award Number R01AR0563282. The content is solely the 
responsibility of the authors and does not necessarily represent the official views of the National Institutes of 
Health. Funding was also provided by The Mayday Fund and The American Pain Society via a Future Leaders in 
Pain grant, and by the United States Army Medical Research and Materiel Command Combat Casualty Care 
Research and the Clinical and Rehabilitative Medicine Research programs. The opinions or assertions contained 
herein are the private views of the author and are not to be construed as official or as reflecting the views of the 
Department of the Army or the Department of Defense.
References
[1]. U.S. Census Bureau. Statistical Abstract of the United States: 2012. Washington, DC: 2011. 
[2]. Arnold M, Ellwanger DC, Hartsperger ML, Pfeufer A. 
[3]. Bak M, Silahtaroglu A, Moller M, Christensen M, Rath MF, Skryabin B, Tommerup N, Kauppinen 
S. MicroRNA expression in the adult mouse central nervous system. Rna. 2008; 14(3):432–444. 
[PubMed: 18230762] 
[4]. Ballina LE, Ulirsch JC, Soward AC, Rossi C, Rotolo S, Linnstaedt SD, Heafner T, Foley KA, Batts 
J, Collette R, Holbrook D, Zelman S, McLean SA. mu-Opioid receptor gene A118G 
polymorphism predicts pain recovery after sexual assault. J Pain. 2013; 14(2):165–171. 
[PubMed: 23260451] 
[5]. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2):215–233. 
[PubMed: 19167326] 
[6]. Bernardo BC, Gao X-M, Winbanks CE, Boey EJ, Tham YK, Kiriazis H, Gregorevic P, Obad S, 
Kauppinen S, Du X-J. Therapeutic inhibition of the miR-34 family attenuates pathological 
cardiac remodeling and improves heart function. Proceedings of the National Academy of 
Sciences. 2012; 109(43):17615–17620.
[7]. Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, Kaluza D, Tréguer K, Carmona G, 
Bonauer A. MicroRNA-34a regulates cardiac ageing and function. Nature. 2013; 495(7439):107–
110. [PubMed: 23426265] 
[8]. Bortsov AV, Diatchenko L, McLean SA. Complex multilocus effects of catechol-O-
methyltransferase haplotypes predict pain and pain interference 6 weeks after motor vehicle 
collision. Neuromolecular medicine. 2014; 16(1):83–93. [PubMed: 23963787] 
[9]. Bortsov AV, Smith JE, Diatchenko L, Soward AC, Ulirsch JC, Rossi C, Swor RA, Hauda WE, 
Peak DA, Jones JS, Holbrook D, Rathlev NK, Foley KA, Lee DC, Collette R, Domeier RM, 
Hendry PL, McLean SA. Polymorphisms in the glucocorticoid receptor co-chaperone FKBP5 
predict persistent musculoskeletal pain after traumatic stress exposure. Pain. 2013
[10]. Brodersen P, Voinnet O. Revisiting the principles of microRNA target recognition and mode of 
action. Nature reviews Molecular cell biology. 2009; 10(2):141–148. [PubMed: 19145236] 
[11]. Brunet A, Weiss DS, Metzler TJ, Best SR, Neylan TC, Rogers C, Fagan J, Marmar CR. The 
Peritraumatic Distress Inventory: a proposed measure of PTSD criterion A2. The American 
journal of psychiatry. 2001; 158(9):1480–1485. [PubMed: 11532735] 
[12]. Bruno AE, Li L, Kalabus JL, Pan Y, Yu A, Hu Z. miRdSNP: a database of disease-associated 
SNPs and microRNA target sites on 3′UTRs of human genes. BMC genomics. 2012; 13:44. 
[PubMed: 22276777] 
[13]. Bryant RA, Moulds ML, Guthrie RM. Acute Stress Disorder Scale: a self-report measure of acute 
stress disorder. Psychological Assessment. 2000; 12(1):61. [PubMed: 10752364] 
Linnstaedt et al. Page 12
Pain. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
[14]. Capuano M, Iaffaldano L, Tinto N, Montanaro D, Capobianco V, Izzo V, Tucci F, Troncone G, 
Greco L, Sacchetti L. MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce 
goblet cells characterize the small intestine of celiac patients. PloS one. 2011; 6(12):e29094. 
[PubMed: 22194996] 
[15]. Christensen NJ. The biochemical assessment of sympathoadrenal activity in man. Clinical 
Autonomic Research. 1991; 1(2):167–172. [PubMed: 1822765] 
[16]. Clark PM, Loher P, Quann K, Brody J, Londin ER, Rigoutsos I. Argonaute CLIP-Seq reveals 
miRNA targetome diversity across tissue types. Scientific reports. 2014:4.
[17]. Concepcion CP, Han Y-C, Mu P, Bonetti C, Yao E, D’andrea A, Vidigal JA, Maughan WP, 
Ogrodowski P, Ventura A. Intact p53-dependent responses in miR-34–deficient mice. PLoS 
Genet. 2012; 8(7):e1002797. [PubMed: 22844244] 
[18]. Dias BG, Goodman JV, Ahluwalia R, Easton AE, Andero R, Ressler KJ. Amygdala-dependent 
fear memory consolidation via miR-34a and notch signaling. Neuron. 2014; 83(4):906–918. 
[PubMed: 25123309] 
[19]. Donello JE, Guan Y, Tian M, Cheevers CV, Alcantara M, Cabrera S, Raja SN, Gil DW. A 
peripheral adrenoceptor-mediated sympathetic mechanism can transform stress-induced analgesia 
into hyperalgesia. The Journal of the American Society of Anesthesiologists. 2011; 114(6):1403–
1416.
[20]. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. A third-generation 
lentivirus vector with a conditional packaging system. Journal of virology. 1998; 72(11):8463–
8471. [PubMed: 9765382] 
[21]. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in 
mammalian cells. Nature methods. 2007; 4(9):721–726. [PubMed: 17694064] 
[22]. Elefant N, Altuvia Y, Margalit H. A wide repertoire of miRNA binding sites: prediction and 
functional implications. Bioinformatics. 2011; 27(22):3093–3101. [PubMed: 21953484] 
[23]. Finley JC Jr. O’Leary M, Wester D, MacKenzie S, Shepard N, Farrow S, Lockette W. A genetic 
polymorphism of the alpha2-adrenergic receptor increases autonomic responses to stress. Journal 
of applied physiology. 2004; 96(6):2231–2239. [PubMed: 14742450] 
[24]. Forte E, Salinas RE, Chang C, Zhou T, Linnstaedt SD, Gottwein E, Jacobs C, Jima D, Li QJ, 
Dave SS, Luftig MA. The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA 
MiR-34a is growth promoting in EBV-infected B cells. J Virol. 2012; 86(12):6889–6898. 
[PubMed: 22496226] 
[25]. Gold MS, Dastmalchi S, Levine JD. Alpha 2-adrenergic receptor subtypes in rat dorsal root and 
superior cervical ganglion neurons. Pain. 1997; 69(1-2):179–190. [PubMed: 9060029] 
[26]. Gottwein E, Cullen BR. A human herpesvirus microRNA inhibits p21 expression and attenuates 
p21-mediated cell cycle arrest. Journal of virology. 2010; 84(10):5229–5237. [PubMed: 
20219912] 
[27]. Haramati S, Navon I, Issler O, Ezra-Nevo G, Gil S, Zwang R, Hornstein E, Chen A. MicroRNA 
as repressors of stress-induced anxiety: the case of amygdalar miR-34. The Journal of 
neuroscience : the official journal of the Society for Neuroscience. 2011; 31(40):14191–14203. 
[PubMed: 21976504] 
[28]. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The human 
genome browser at UCSC. Genome research. 2002; 12(6):996–1006. [PubMed: 12045153] 
[29]. Khasar SG, Burkham J, Dina OA, Brown AS, Bogen O, Alessandri-Haber N, Green PG, 
Reichling DB, Levine JD. Stress induces a switch of intracellular signaling in sensory neurons in 
a model of generalized pain. The Journal of neuroscience : the official journal of the Society for 
Neuroscience. 2008; 28(22):5721–5730. [PubMed: 18509033] 
[30]. Khasar SG, Dina OA, Green PG, Levine JD. Sound Stress–Induced Long-Term Enhancement of 
Mechanical Hyperalgesia in Rats Is Maintained by Sympathoadrenal Catecholamines. The 
Journal of Pain. 2009; 10(10):1073–1077. [PubMed: 19576859] 
[31]. Khasar SG, McCarter G, Levine JD. Epinephrine produces a β-adrenergic receptor-mediated 
mechanical hyperalgesia and in vitro sensitization of rat nociceptors. Journal of neurophysiology. 
1999; 81(3):1104–1112. [PubMed: 10085337] 
Linnstaedt et al. Page 13
Pain. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
[32]. Kohli U, Muszkat M, Sofowora GG, Harris PA, Friedman EA, Dupont WD, Scheinin M, Wood 
AJ, Stein CM, Kurnik D. Effects of variation in the human alpha2A- and alpha2C-adrenoceptor 
genes on cognitive tasks and pain perception. Eur J Pain. 2010; 14(2):154–159. [PubMed: 
19423370] 
[33]. Kruger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. 
Nucleic acids research. 2006; 34(Web Server issue):W451–454. [PubMed: 16845047] 
[34]. Lebow M, Neufeld-Cohen A, Kuperman Y, Tsoory M, Gil S, Chen A. Susceptibility to PTSD-
like behavior is mediated by corticotropin-releasing factor receptor type 2 levels in the bed 
nucleus of the stria terminalis. The Journal of neuroscience : the official journal of the Society for 
Neuroscience. 2012; 32(20):6906–6916. [PubMed: 22593059] 
[35]. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates 
that thousands of human genes are microRNA targets. cell. 2005; 120(1):15–20. [PubMed: 
15652477] 
[36]. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR. Virally induced cellular 
microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol. 
2010; 84(22):11670–11678. [PubMed: 20844043] 
[37]. McCracken JT, Badashova KK, Posey DJ, Aman MG, Scahill L, Tierney E, Arnold LE, Vitiello 
B, Whelan F, Chuang SZ, Davies M, Shah B, McDougle CJ, Nurmi EL. Positive effects of 
methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children 
with autism spectrum disorders. The pharmacogenomics journal. 2014; 14(3):295–302. 
[PubMed: 23856854] 
[38]. McLean SA, Soward AC, Ballina LE, Rossi C, Rotolo S, Wheeler R, Foley KA, Batts J, Casto T, 
Collette R, Holbrook D, Goodman E, Rauch SA, Liberzon I. Acute severe pain is a common 
consequence of sexual assault. J Pain. 2012; 13(8):736–741. [PubMed: 22698980] 
[39]. Meloto CB, Bortsov A, Bair E, Helgeson E, Ostrom C, Smith S, Dubner R, Slade GD, Fillingim 
RB, Greenspan JD, Ohrbach R, Maixner W, McLean S, Diatchenko L. Modification of COMT-
dependent pain sensitivity by psychological stress and sex. Pain. 2015
[40]. Nemoto T, Mano A, Shibasaki T. miR-449a contributes to glucocorticoid-induced CRF-R1 
downregulation in the pituitary during stress. Molecular Endocrinology. 2013; 27(10):1593–
1602. [PubMed: 23893957] 
[41]. Nishi D, Matsuoka Y, Yonemoto N, Noguchi H, Kim Y, Kanba S. Peritraumatic Distress 
Inventory as a predictor of post-traumatic stress disorder after a severe motor vehicle accident. 
Psychiatry and clinical neurosciences. 2010; 64(2):149–156. [PubMed: 20447011] 
[42]. Norris FH. Epidemiology of trauma: frequency and impact of different potentially traumatic 
events on different demographic groups. Journal of consulting and clinical psychology. 1992; 
60(3):409. [PubMed: 1619095] 
[43]. Norton PJ, Asmundson GJ. Amending the fear-avoidance model of chronic pain: what is the role 
of physiological arousal? Behavior Therapy. 2003; 34:17–30.
[44]. Peaston RT, Weinkove C. Measurement of catecholamines and their metabolites. Annals of 
clinical biochemistry. 2004; 41(1):17–38. [PubMed: 14713382] 
[45]. Platts-Mills TFBL, Bortsov AV, Soward A, Swor RA, Jones JS, Lee DC, Peak DA, Domeier RM, 
Rathlev NK, Hendry PL, McLean SA. Using emergency department-based inception cohorts to 
determine genetic characteristics associated with long term patient outcomes after motor vehicle 
collision: methodology of the CRASH study. BMC Emerg Med. 2011; 11(14)
[46]. Quintero L, Moreno M, Avila C, Arcaya J, Maixner W, Suarez-Roca H. Long-lasting delayed 
hyperalgesia after subchronic swim stress. Pharmacology, Biochemistry, and Behavior. 2000; 
67(3):449–458.
[47]. Rabinovsky ED, Le WD, McManaman JL. Differential effects of neurotrophic factors on 
neurotransmitter development in the IMR-32 human neuroblastoma cell line. The Journal of 
neuroscience : the official journal of the Society for Neuroscience. 1992; 12(1):171–179. 
[PubMed: 1345944] 
[48]. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren 
M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Molecular cell. 
2007; 26(5):731–743. [PubMed: 17540598] 
Linnstaedt et al. Page 14
Pain. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
[49]. Resnick HS, Kilpatrick DG, Dansky BS, Saunders BE, Best CL. Prevalence of civilian trauma 
and posttraumatic stress disorder in a representative national sample of women. J Consult Clin 
Psychol. 1993; 61(6):984–991. [PubMed: 8113499] 
[50]. Rubin DH, Althoff RR, Ehli EA, Davies GE, Rettew DC, Crehan ET, Walkup JT, Hudziak JJ. 
Candidate gene associations with withdrawn behavior. Journal of child psychology and 
psychiatry, and allied disciplines. 2013; 54(12):1337–1345.
[51]. Sands S, Strong R, Corbitt J, Morilak D. Effects of acute restraint stress on tyrosine hydroxylase 
mRNA expression in locus coeruleus of Wistar and Wistar-Kyoto rats. Brain research Molecular 
brain research. 2000; 75(1):1. [PubMed: 10648882] 
[52]. Shenoda BB, Alexander GM, Ajit SK. Hsa-miR-34a mediated repression of corticotrophin 
releasing hormone receptor 1 regulates pro-opiomelanocortin expression in patients with 
complex regional pain syndrome. Journal of Translational Medicine. 2016; 14(1):1. [PubMed: 
26727970] 
[53]. Silber J, Jacobsen A, Ozawa T, Harinath G, Pedraza A, Sander C, Holland EC, Huse JT. miR-34a 
repression in proneural malignant gliomas upregulates expression of its target PDGFRA and 
promotes tumorigenesis. PLoS One. 2012; 7(3):e33844. [PubMed: 22479456] 
[54]. Small KM, Brown KM, Seman CA, Theiss CT, Liggett SB. Complex haplotypes derived from 
noncoding polymorphisms of the intronless α2A-adrenergic gene diversify receptor expression. 
Proceedings of the National Academy of Sciences. 2006; 103(14):5472–5477.
[55]. Stone LS, Broberger C, Vulchanova L, Wilcox GL, Hokfelt T, Riedl MS, Elde R. Differential 
distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. 
The Journal of neuroscience : the official journal of the Society for Neuroscience. 1998; 18(15):
5928–5937. [PubMed: 9671679] 
[56]. Stone LS, Vulchanova L, Riedl MS, Wang J, Williams FG, Wilcox GL, Elde R. Effects of 
peripheral nerve injury on alpha-2A and alpha-2C adrenergic receptor immunoreactivity in the rat 
spinal cord. Neuroscience. 1999; 93(4):1399–1407. [PubMed: 10501465] 
[57]. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces 
senescence-like growth arrest through modulation of the E2F pathway in human colon cancer 
cells. Proceedings of the National Academy of Sciences. 2007; 104(39):15472–15477.
[58]. Ulirsch JC, Weaver MA, Bortsov AV, Soward AC, Swor RA, Peak DA, Jones JS, Rathlev NK, 
Lee DC, Domeier RM, Hendry PL, McLean SA. No man is an island: living in a disadvantaged 
neighborhood influences chronic pain development after motor vehicle collision. Pain. 2014; 
155(10):2116–2123. [PubMed: 25107859] 
[59]. Valastyan S, Weinberg RA. Assaying microRNA loss-of-function phenotypes in mammalian 
cells: emerging tools and their potential therapeutic utility. RNA biology. 2009; 6(5):541–545. 
[PubMed: 19901530] 
[60]. von Schack D, Agostino MJ, Murray BS, Li Y, Reddy PS, Chen J, Choe SE, Strassle BW, Li C, 
Bates B, Zhang L, Hu H, Kotnis S, Bingham B, Liu W, Whiteside GT, Samad TA, Kennedy JD, 
Ajit SK. Dynamic changes in the microRNA expression profile reveal multiple regulatory 
mechanisms in the spinal nerve ligation model of neuropathic pain. PloS one. 2011; 6(3):e17670. 
[PubMed: 21423802] 
[61]. West GJ, Uki J, Herschman HR, Seeger RC. Adrenergic, cholinergic, and inactive human 
neuroblastoma cell lines with the action-potential Na+ ionophore. Cancer research. 1977; 37(5):
1372–1376. [PubMed: 15722] 
[62]. Yang L, Qian Q, Liu L, Li H, Faraone SV, Wang Y. Adrenergic neurotransmitter system 
transporter and receptor genes associated with atomoxetine response in attention-deficit 
hyperactivity disorder children. Journal of neural transmission. 2013; 120(7):1127–1133. 
[PubMed: 23266789] 
Linnstaedt et al. Page 15
Pain. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Summary
ADRA2A variant rs3750625 alters a miR-34a binding site and is associated with acute 
pain severity following motor vehicle collision and sexual assault traumas.
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Figure 1. 
rs3750625 is in the seed binding region of miR-34a (A) rs3750625 (black arrow, bolded 
nucleotides) maps within a potential seed binding site for miR-34a. Predicted base pairing 
between miR-34a and the ADRA2A 3′UTR with either the major or minor allele is 
indicated by a solid vertical line (Watson-Crick) or by a gray dot (wobble). The seed region 
of miR-34a (nucleotides 2-8) is underlined. (B) Nucleotide conservation amongst 7 
mammals in the miR-34a binding region of ADRA2A. The arrow indicates the location of 
rs3750625. Conserved nucleotides are greyed.
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Figure 2. 
Acute MSP following trauma is more severe in individuals with the minor allele at 
ADRA2A rs3750625 who also reported stress in the early aftermath of trauma exposure. (A) 
Following sexual assault, MSP severity was higher in stressed individuals with at least one 
copy of the ADRA2A rs3750625 minor allele (CA/AA) versus individuals with the major 
allele (CC), *p = 0.020. Non-stressed individuals with at least one copy of the ADRA2A 
rs3750625 minor allele reported lower MSP severity, p = 0.116. A stress cut-off of 77 was 
used to distinguish stressed from non-stressed individuals (ASD scale, median) (B) A 
Linnstaedt et al. Page 18
Pain. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
similar crossover interaction was observed following motor vehicle collision. A distress cut 
off of 23 was used to distinguish distressed from non-distressed individuals (PDI scale, 
previously validated cut-off[41]).
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Figure 3. 
Characterization and functional assessment of miR-34a binding to the 3′UTR of ADRA2A. 
(A) miR-34a binding to the 3′UTR of ADRA2A containing the major allele at rs3750625. 
Relative luciferase activity (y axis) indicates miR-34a binding to ADRA2A (black bars) in a 
dose-dependent manner. Transfection of a control miRNA was used to determine 
background luciferase activity (open bars). Each experiment was repeated three times in 
triplicate, error bars show standard error of the mean. (B) Comparison of miR-34a binding to 
the 3′UTR of ADRA2A with the minor allele (grey line, grey squares) versus the major 
allele (black line, black circles) at rs3750625. Error bars show standard error of the mean 
based on three experimental replicates. Differences in luciferase activity between the major 
and minor alleles was significant at all three concentrations of miRNA added. **p < 0.005 
(Mann-Whitney U test). (C) Relative location of the miR-34a binding site in the context of 
the 1.4kb ADRA2A 3′UTR. Mutations that destabilize base pairing (greyed and bolded 
nucleotides) were made in either the seed binding region or the compensatory binding region 
of pL-GL3-ADRA2A-maj. (D) Relative luciferase activity was measured for miR-34a 
binding (150fmol) to the ADRA2A 3′UTR with no mutations (WT), with mutations in the 
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seed region (seed mut) or with mutations in the compensatory region (comp mut). Results 
are the average of three experiments performed in triplicate. Error bars show standard 
deviation.
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Figure 4. 
miR-34a regulates ADRA2A expression in neuroblastoma cells. miR-34a was knocked 
down in the IMR-32 adrenergic neuroblastoma cell line using a sponge construct, pLCE-s34. 
(A) ADRA2A mRNA expression was measured by RT-qPCR of RNA isolated from IMR-32 
cells expressing pLCE-s34 (s34). Levels of ADRA2A mRNA expression in s34 were 
calculated relative to IMR-32 cells expressing empty vector (pLCE) or control sponge 
(sCXCR4). Quantification of mRNA was performed three times in duplicate. Error bars 
show standard deviation. * p < 0.05 (Mann-Whitney U test). (B) ADRA2A protein levels 
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from cell lysates of sponge (and control) expressing IMR-32 cells were measured by 
Western Blotting. Quantification of band intensity was calculated using band intensity 
measurements from the NIH image analysis program, Image J.
Linnstaedt et al. Page 23
Pain. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 5. 
Comparison of miR-34a and ADRA2A mRNA expression levels in Sprague-Dawley rats in 
response to forced swim stress exposure in the following tissues: Adrenal Gland (AG), 
Peripheral Nerve (PN), and Dorsal Root Ganglion (DRG). RNA was isolated from rat tissues 
at baseline (no stress exposure) and from rat tissues after exposure to 30 minutes of repeated 
forced swim stress on three consecutive days. RT-qPCR was used for miR-34a and 
ADRA2A mRNA quantification. Fold change was calculated from a minimum of three 
independent experiments performed in duplicate. Error bars represent standard deviations.
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Table 1
Baseline characteristics of study participants
Characteristic MVC SA
Enrolled, n 948 84
Age, years, mean (SD) 36 (13) 26 (8)
Females, n(%) 575 (61) 84 (100)
Ethnicity
 European American 948 (100) 54 (64)
 African American - 30 (36)
Education, n(%)
 8-11 years 42 (4) 11 (13)
 HS 184 (19) 16 (19)
 Post-HS training (not college) 57 (6) 1 (1)
 Some college 311 (33) 43 (51)
 College 237 (25) 9 (11)
 Post-college 113 (12) 3 (4)
Overall ED pain, 0-10 NRS, mean(SD) 5.5 (2.4) 6.8 (2.9)
Distress in the early aftermath of trauma,
PDI scale (MVC) and ASD (SA), median 18 77
MVC = motor vehicle collision, SA = sexual assault, SD = standard deviation, HS = high-school, ED = emergency department, NRS = numeric 
rating scale, PDI = peritraumatic distress inventory, ASD = acute stress disorder scale
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TABLE 2
General linear model examining the relationship between candidate predictors and overall acute pain severity 
following Motor Vehicle Collision (n = 922) and sexual assault (n = 80).
Motor Vehicle Collision Sexual Assault
Variablea F p value F p value
Age 3.83 0.051 <0.001 0.999
Sex 0.037 0.947 N/A N/A
Peritraumatic distressb 34.19 <0.001 0.011 0.918
rs3750625c 3.224 0.073 5.432 0.007
rs3750625 * sex 0.102 0.750 N/A N/A
rs3750625 * distress 4.103 0.043 5.467 0.007
a
study site was also included as a categorical variable
b
For the MVC cohort distress was assessed in the Emergency Department using the Peritraumatic Distress Inventory[11], For the sexual assault 
cohort distress was assessed using the Acute Stress Disorder Questionnaire[13].
c
Dominant genetic model used for rs3750625
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